Telix Pharmaceuticals Limited Share Price
Stocks
TLX
AU000000TLX2
Biotechnology & Medical Research
OTC Markets Traded|
Delayed
Australian S.E.
04:45:51 30/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 13.20 AUD | -2.08% |
|
-3.22% | +18.04% |
| Market Cap | 458.03Cr 321.72Cr 287.37Cr 264.73Cr 240.05Cr 449.78Cr 31TCr 3.16TCr 1.26TCr 16TCr 1.21TCr 1.18TCr 51TCr | P/E 2026 * |
203x | P/E 2027 * | 2,399x |
|---|---|---|---|---|---|
| Enterprise Value | 510.9Cr 358.85Cr 320.54Cr 295.29Cr 267.76Cr 501.7Cr 34TCr 3.53TCr 1.41TCr 18TCr 1.35TCr 1.32TCr 57TCr | EV / Sales 2026 * |
3.67x | EV / Sales 2027 * | 3.22x |
| Free-Float |
84.31% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Australian S.E.
| TLX | Delayed | |
Tradegate
| T3X | Real-time | |
|
OTC Markets
| TLPPF | Delayed | |
|
Boerse Muenchen
| T3X | Real-time | |
|
Deutsche Boerse AG
| T3X | Delayed | |
|
Börse Stuttgart
| T3X | Delayed |
Last Transcript: Telix Pharmaceuticals Limited
| 1 day | -1.93% | ||
| 1 week | -3.22% | ||
| Current month | -15.90% | ||
| 1 month | -18.14% | ||
| 3 months | -8.83% | ||
| 6 months | -11.87% | ||
| Current year | +18.04% |
| 1 week | 12.61 |  | 13.86 |
| 1 month | 12.61 | | 16.5 |
| Current year | 8.26 | | 18.22 |
| 1 year | 8.26 | | 18.22 |
| 3 years | 8.26 | | 31.97 |
| 5 years | 3.55 | | 31.97 |
| 10 years | 0.46 | | 31.97 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 51 | 03/01/2017 | |
Darren Smith
DFI | Director of Finance/CFO | 61 | 31/07/2022 |
| Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 51 | 03/01/2017 | |
Mark Nelson
CHM | Chairman | 66 | 03/02/2026 |
Jann Skinner
BRD | Director/Board Member | 68 | 19/06/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 24/09/26 | Buy | Chairman | 11,800 | 0.0035% | ||
| 07/09/26 | Buy | Chief Financial Officer | 2,071 | 0.0006% | ||
| 26/05/26 | Free | Director | 21,597 | 0.0064% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.08% | -3.22% | -18.24% | +49.89% | 312.4Cr | |
| +0.34% | -3.03% | +37.45% | +61.06% | 6.41TCr | |
| +0.98% | +2.26% | +12.91% | +82.98% | 5.55TCr | |
| +1.75% | +2.76% | +12.38% | +103.69% | 5.3TCr | |
| -1.43% | -0.57% | +26.10% | +52.86% | 4.6TCr | |
| -0.48% | -3.86% | +17.27% | +117.99% | 4.25TCr | |
| +0.82% | -2.06% | +227.09% | +922.41% | 4.04TCr | |
| -0.26% | -4.20% | +10.86% | +45.18% | 3.23TCr | |
| -2.07% | +44.58% | +102.84% | +88.74% | 3.45TCr | |
| -2.72% | -8.79% | +22.58% | -5.63% | 2.42TCr | |
| Average | -0.50% | +2.43% | +45.12% | +151.92% | 3.96TCr | |
| Weighted average by Cap. | -0.09% | +3.03% | +48.73% | +160.01% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 139.12Cr 98Cr 87Cr 80Cr 73Cr 136.62Cr 9.3TCr 960.27Cr 382.87Cr 4.88TCr 366.54Cr 358.74Cr 15TCr | 157.33Cr 110.51Cr 99Cr 91Cr 82Cr 154.5Cr 11TCr 1.09TCr 432.97Cr 5.52TCr 414.5Cr 405.68Cr 17TCr |
| Net income | 2.7Cr 1.9Cr 1.7Cr 1.56Cr 1.42Cr 2.65Cr 180.63Cr 19Cr 7.44Cr 95Cr 7.12Cr 6.97Cr 299.29Cr | 25.07L 17.61L 15.73L 14.49L 13.14L 24.62L 17Cr 1.73Cr 68.99L 8.79Cr 66.04L 64.64L 28Cr |
| Net Debt | 53Cr 37Cr 33Cr 31Cr 28Cr 52Cr 3.53TCr 364.91Cr 145.49Cr 1.85TCr 139.29Cr 136.32Cr 5.86TCr | 49Cr 34Cr 31Cr 28Cr 26Cr 48Cr 3.27TCr 338.03Cr 134.78Cr 1.72TCr 129.03Cr 126.28Cr 5.42TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/26/30 | A$13.20 | -2.08% | 2,33,968 |
| 29/26/29 | A$13.48 | +3.22% | 18,03,720 |
| 28/26/28 | A$13.06 | +2.11% | 40,42,702 |
| 27/26/27 | A$12.79 | -0.47% | 29,45,488 |
| 26/26/26 | A$12.85 | -2.58% | 44,18,896 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- TLX Stock
Select your edition
All financial news and data tailored to specific country editions
